VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2020 SESSION

• | print version

SB 885 Performance of laboratory analysis; cannabidiol oil, THC-A oil, tetrahydrocannabinol.

Introduced by: David W. Marsden | all patrons    ...    notes | add to my profiles | history

SUMMARY AS PASSED SENATE:

Performance of laboratory analysis; cannabidiol oil; THC-A oil; tetrahydrocannabinol. Provides that no person employed by an analytical laboratory to retrieve, deliver, or possess cannabidiol oil, THC-A oil, or industrial hemp samples from a permitted pharmaceutical processor, a licensed industrial hemp grower, or a licensed industrial hemp processor for the purpose of performing required testing shall be prosecuted for the possession or distribution of cannabidiol oil, THC-A oil, or industrial hemp, or for storing cannabidiol oil, THC-A oil, or industrial hemp for testing purposes in accordance with regulations promulgated by the Board of Pharmacy and the Board of Agriculture and Consumer Services. The bill contains an emergency clause.

SUMMARY AS INTRODUCED:

Performance of laboratory analysis; cannabidiol oil; THC-A oil; tetrahydrocannabinol. Provides that no person employed by an analytical laboratory to retrieve, deliver, or possess cannabidiol oil or THC-A oil samples from a permitted pharmaceutical processor for performing required testing shall be prosecuted for the possession or distribution of cannabidiol oil or THC-A oil for storing cannabidiol oil or THC-A oil for testing purposes in accordance with regulations promulgated by the Board of Pharmacy. The bill requires practitioners to register with the Board of Pharmacy to conduct laboratory analysis on tetrahydrocannabinol or marijuana and exempts practitioners conducting laboratory research on tetrahydrocannabinol from furnishing evidence of federal registration. The bill contains an emergency clause.